Alosetron Hydrochloride Production Cost Reports

The report provides a detailed analysis essential for establishing an alosetron hydrochloride production plant. It encompasses all critical aspects necessary for alosetron hydrochloride production, including the cost of alosetron hydrochloride production, alosetron hydrochloride plant cost, alosetron hydrochloride production costs, and the overall alosetron hydrochloride production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating an alosetron hydrochloride production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.

Alosetron hydrochloride is a medication that is used for treating severe diarrhoea-predominant irritable bowel syndrome (IBS-D) in women. It is effective in those who do not respond to conventional therapies. It works as a selective 5-HT3 receptor antagonist to block serotonin effects in the gut, which slows intestinal transit.

It reduces abdominal pain, cramping, urgency, and stool frequency for sustained symptom relief. It targets chronic IBS cases lasting over six months without structural abnormalities and offers targeted control of discomfort and diarrhoea through low-dose oral tablets. It is not suitable for men, constipation-predominant IBS, or other GI disorders. Its common side effects include constipation, nausea, abdominal discomfort, pain, distention, gas, and, less often, headache, fatigue, or haemorrhoids.

The market for alosetron hydrochloride is influenced by increasing cases of irritable bowel syndrome (IBS-D). The rise in ageing women, greater diagnostic awareness, healthcare infrastructure expansions, and availability of generics fuel its market. The North American region leads its market because of strong reimbursement and R&D into more applications.

The marketing initiatives, direct-to-consumer awareness campaigns, and growth of e-commerce penetration in the Asia-Pacific regions boost its market. The careful FDA risk management protocols, because of ischemic colitis and constipation risks, and high compliance costs for GMP-certified API production impacts industrial alosetron hydrochloride procurement. Other factors like supply chain disruptions from tariffs, dual-sourcing mandates, and generic pricing after patent expiry affect its sourcing strategies.

Raw Material for Alosetron Hydrochloride Production

According to the alosetron hydrochloride production plant project report, the key raw materials used in the production of alosetron hydrochloride include 2,3,4,5-tetrahydro-5-methyl-1H-pyrido[4,3-b]indol-1-one | 4-hydroxymethyl-5-methylimidazole | trifluoroacetic acid |hydrochloric acid.

Production Process of Alosetron Hydrochloride

The extensive alosetron hydrochloride production cost report consists of the following major industrial production process:

1. From acid-catalysed condensation: The production of alosetron hydrochloride starts with the acid-catalysed condensation of 2,3,4,5-tetrahydro-5-methyl-1H-pyrido[4,3-b]indol-1-one and 4-hydroxymethyl-5-methylimidazole. This takes place in the presence of trifluoroacetic acid to form alosetron base. The base is dissolved in methanol and treated with IPA. This is followed by treatment with hydrochloric acid that leads to the formation of alosetron hydrochloride.

Alosetron hydrochloride has the molecular formula of C17H19ClN4O and a molecular weight of 330.81 g/mol. It appears as a white to beige or light-yellow crystalline powder or solid with a melting point of 288-291 degree Celsius. It has high thermal stability, relative density around 0.6, and solubility of ≥5 mg/mL in warm water, and lower in neutral buffers. It has a log Pow value of 1.6, making it moderately lipophilic. It requires storage at 2-8 degree Celsius. It is achiral with a polar surface area of 53.92 Ų, two hydrogen bond acceptors, one donor, zero charge at pH 7.4, and two rotatable bonds. It shows hazard classifications including acute oral toxicity (H301), eye irritation (H319), and aquatic chronic hazard (H412).